izpis_h1_title_alt

Compensational role between cathepsins
ID Pečar Fonović, Urša (Author), ID Kos, Janko (Author), ID Mitrović, Ana (Author)

.pdfPDF - Presentation file, Download (1004,70 KB)
MD5: 20CAE8071608BE8508298C28D618D1AB
URLURL - Source URL, Visit https://www.sciencedirect.com/science/article/pii/S0300908424000853 This link opens in a new window

Abstract
Cathepsins, a family of lysosomal peptidases, play a crucial role in maintaining cellular homeostasis by regulating protein turnover and degradation as well as many specific regulatory actions that are important for proper cell function and human health. Alterations in the activity and expression of cathepsins have been observed in many diseases such as cancer, inflammation, neurodegenerative disorders, bone remodelling-related conditions and others. These changes are not exclusively harmful, but rather appear to be a compensatory response on the lack of one cathepsin in order to maintain tissue integrity. The upregulation of specific cathepsins in response to the inhibition or dysfunction of other cathepsins suggests a fine-tuned system of proteolytic balance and understanding the compensatory role of cathepsins may improve therapeutic potential of cathepsin's inhibitors. Selectively targeting one cathepsin or modulating their activity could offer new treatment strategies for a number of diseases. This review emphasises the need for comprehensive research into cathepsin biology in the context of disease. The identification of the specific cathepsins involved in compensatory responses, the elucidation of the underlying molecular mechanisms and the development of targeted interventions could lead to innovative therapeutic approaches.

Language:English
Keywords:lysosomal peptidases, compensation, bone resorption, cancer, inflammation, neurodegeneration
Work type:Article
Typology:1.02 - Review Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2024
Number of pages:Str. 62-76
Numbering:Vol. 226
PID:20.500.12556/RUL-164680 This link opens in a new window
UDC:577
ISSN on article:1638-6183
DOI:10.1016/j.biochi.2024.04.010 This link opens in a new window
COBISS.SI-ID:193579011 This link opens in a new window
Publication date in RUL:07.11.2024
Views:71
Downloads:16
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Biochimie
Shortened title:Biochimie
Publisher:Elsevier, Société Française de Biochimie et Biologie Moléculaire
ISSN:1638-6183
COBISS.SI-ID:193576195 This link opens in a new window

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.

Secondary language

Language:Slovenian
Keywords:katepsini, rak, vnetje, nevrodegenerativne bolezni

Projects

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-3071
Name:Katepsina B in X v tumorskih matičnih celicah raka dojke – molekulske tarče in pomen za protitumorno terapijo

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P4-0127
Name:Farmacevtska biotehnologija: znanost za zdravje

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back